Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.39 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | LIPE | Q05469 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1686141 | 0.81 | ALDH1A1 (0.67) | ALDH1A1RECQLMMP8LIPGMAPT | |
| SCHEMBL28168069 | 0.78 | ALDH1A1 (0.67) | ALDH1A1RECQLMMP8CTRB1MAPT | |
| SCHEMBL7425417 | 0.78 | CYP2C19 (0.47) | ALDH1A1MAPTCYP3A4TSHR | |
| SCHEMBL7362946 | 0.77 | LIPG (0.43) | LIPGLIPE | |
| SCHEMBL339395 | 0.73 | ALDH1A1 (0.56) | ALDH1A1RECQLMMP8MAPTTSHR | |
| SCHEMBL8315892 | 0.73 | PKM (0.48) | MAPTMTNR1A | |
| SCHEMBL12494192 | 0.71 | SETDB1 (0.50) | ALDH1A1LIPGMTNR1AMTNR1B | |
| SCHEMBL410387 | 0.71 | LIPG (0.61) | ALDH1A1LIPGMAPTLIPE | |
| SCHEMBL29468961 | 0.71 | LIPG (0.61) | ALDH1A1LIPGMAPTLIPE | |
| SCHEMBL29166051 | 0.71 | FDPS (0.45) | ALDH1A1RECQLMMP8MAPTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110104076-A1 | Compositions, Methods For Preparing Amino Acids And Nuclear Magnetic Resonance Spectroscopy | GLYCONIX CORPORATION | 2011-05-05 | — | — | US | disclosed |
| WO-2007070195-A2 | COMPOSITIONS, METHODS OF PREPARING AMINO ACIDS AND NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | GLYCONIX CORPORATION (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070104648-A1 | Compositions, methods of preparing amino acids, and nuclear magnetic resonance spectroscopy | GLYCONIX CORPORATION | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104076-A1 | Compositions, Methods For Preparing Amino Acids And Nuclear Magnetic Resonance Spectroscopy | BCAT1, BCAT2, SLC3A2 | ALDH1A1 3752/4885RECQL 4019/4885MMP8 4420/4885 |
| US-20070104648-A1 | Compositions, methods of preparing amino acids, and nuclear magnetic resonance spectroscopy | BCAT1, BCAT2, SLC3A2 | ALDH1A1 3717/4885RECQL 4180/4885MMP8 4571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.